HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

David F Bishop Selected Research

Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)

1/2011Congenital erythropoietic porphyria: characterization of murine models of the severe common (C73R/C73R) and later-onset genotypes.
9/2010Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
2/2010Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.
4/2006Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.
6/2002Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


David F Bishop Research Topics

Disease

6Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
01/2011 - 06/2002
4Acute Intermittent Porphyria (Porphyria, Acute)
02/2010 - 11/2004
3Hepatic Porphyrias (Hepatic Porphyria)
02/2011 - 01/2010
1Erythropoietic Protoporphyria
01/2013
1Liver Diseases (Liver Disease)
01/2013
1Developmental Bone Diseases (Bone Dysplasia)
04/2012
1Bone Neoplasms (Bone Cancer)
04/2012
1Muscular Diseases (Myopathy)
04/2012
1Hereditary Coproporphyria (Coproporphyrinogen Oxidase Deficiency)
02/2011
1Hypochromic Anemia (Chlorosis)
01/2011
1Polycythemia (Erythrocytosis)
01/2009
1Anemia
01/2009
1Porphyrias
11/2004
1Neurologic Manifestations (Neurological Manifestations)
11/2004

Drug/Important Bio-Agent (IBA)

7Heme (Haem)IBA
01/2013 - 06/2002
5Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
01/2011 - 06/2002
4Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
02/2010 - 11/2004
2PorphyrinsIBA
01/2011 - 11/2004
1Ferrochelatase (Heme Synthetase)IBA
01/2013
15-Aminolevulinate SynthetaseIBA
01/2013
1ProtoporphyrinsIBA
01/2013
1Diaphyseal medullary stenosis with malignant fibrous histiocytomaIBA
04/2012
1Coproporphyrinogen Oxidase (Coproporphyrinogen III Oxidases)IBA
02/2011
1Hemoglobins (Hemoglobin)IBA
01/2011
1ErythropoietinFDA Link
01/2009
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2009